Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Bionano Genomics Inc.

    NASDAQ: BNGO · Real-Time Price · USD
    3.70
    0.03 (0.82%)
    At close: Jun 12, 2025, 3:59 PM
    3.72
    0.52%
    After-hours: Jun 12, 2025, 07:59 PM EDT

    Bionano Genomics Statistics

    Share Statistics

    Bionano Genomics has 3.36M shares outstanding. The number of shares has increased by -19.3% in one year.

    Shares Outstanding

    n/a
    		 3.36M

    Shares Change (YoY)

    n/a
    		 -19.3%

    Shares Change (QoQ)

    n/a
    		 -18.8%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 3.35M

    Failed to Deliver (FTD) Shares

    n/a
    		 1,777

    FTD / Avg. Volume

    n/a
    		 1.3%

    Short Selling Information

    The latest short interest is 611.11K, so 18.17% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 611.11K

    Short % of Shares Out

    n/a
    		 18.17%

    Short % of Float

    n/a
    		 18.18%

    Short Ratio (days to cover)

    n/a
    		 6.3

    Valuation Ratios

    The PE ratio is -0.29 and the forward PE ratio is -0.9. Bionano Genomics's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.29

    Forward PE

    n/a
    		 -0.9

    PS Ratio

    n/a
    		 1.05

    Forward PS

    n/a
    		 0.2

    PB Ratio

    n/a
    		 0.91

    P/FCF Ratio

    n/a
    		 -0.47

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Bionano Genomics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.06, with a Debt / Equity ratio of 0.77.

    Current Ratio

    n/a
    		 1.06

    Quick Ratio

    n/a
    		 0.76

    Debt / Equity

    n/a
    		 0.77

    Debt / EBITDA

    n/a
    		 -0.28

    Debt / FCF

    n/a
    		 -0.4

    Interest Coverage

    n/a
    		 -359.8

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $314,040.82

    Profits Per Employee

    n/a
    		 $-1,143,030.61

    Employee Count

    n/a
    		 98

    Asset Turnover

    n/a
    		 0.4

    Inventory Turnover

    n/a
    		 2.73

    Taxes

    Income Tax

    n/a
    		 33K

    Effective Tax Rate

    n/a
    		 -0.03%

    Stock Price Statistics

    The stock price has increased by -92.69% in the last 52 weeks. The beta is 2.28, so Bionano Genomics's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.28

    52-Week Price Change

    n/a
    		 -92.69%

    50-Day Moving Average

    n/a
    		 3.83

    200-Day Moving Average

    n/a
    		 11.76

    Relative Strength Index (RSI)

    n/a
    		 46.87

    Average Volume (20 Days)

    n/a
    		 136,842

    Income Statement

    In the last 12 months, Bionano Genomics had revenue of 30.78M and earned -112.02M in profits. Earnings per share was -60.05.

    Revenue

    n/a
    		 30.78M

    Gross Profit

    n/a
    		 380K

    Operating Income

    n/a
    		 -103.98M

    Net Income

    n/a
    		 -112.02M

    EBITDA

    n/a
    		 -97.47M

    EBIT

    n/a
    		 -111.69M

    Earnings Per Share (EPS)

    n/a
    		 -60.05
    Full Income Statement

    Balance Sheet

    The company has 9.17M in cash and 27.3M in debt, giving a net cash position of -18.12M.

    Cash & Cash Equivalents

    n/a
    		 9.17M

    Total Debt

    n/a
    		 27.3M

    Net Cash

    n/a
    		 -18.12M

    Retained Earnings

    n/a
    		 -693.23M

    Total Assets

    n/a
    		 78.41M

    Working Capital

    n/a
    		 18.52M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -68.92M and capital expenditures -103K, giving a free cash flow of -69.03M.

    Operating Cash Flow

    n/a
    		 -68.92M

    Capital Expenditures

    n/a
    		 -103K

    Free Cash Flow

    n/a
    		 -69.03M

    FCF Per Share

    n/a
    		 -37
    Full Cash Flow Statement

    Margins

    Gross margin is 1.23%, with operating and profit margins of -337.87% and -363.98%.

    Gross Margin

    n/a
    		 1.23%

    Operating Margin

    n/a
    		 -337.87%

    Pretax Margin

    n/a
    		 -363.87%

    Profit Margin

    n/a
    		 -363.98%

    EBITDA Margin

    n/a
    		 -316.7%

    EBIT Margin

    n/a
    		 -337.87%

    FCF Margin

    n/a
    		 -224.28%

    Dividends & Yields

    BNGO does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for BNGO is $8, which is 116.2% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $8

    Price Target Difference

    n/a
    		 116.2%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jan 27, 2025. It was a backward split with a ratio of 1:60.

    Last Split Date

    n/a
    		 Jan 27, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:60

    Scores

    Altman Z-Score

    n/a
    		 -15.26

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist